| Abstrakt: |
Researchers at the Chinese Academy of Sciences have conducted a study on tecovirimat, an antiviral drug used to treat monkeypox. The study focused on the identification, synthesis, and control of impurities during the drug's manufacturing process. Through various analytical techniques, the researchers were able to confirm the chemical structure of critical impurities and establish methods to control them. The findings emphasize the importance of impurity characterization and control in pharmaceutical development to ensure the safety and efficacy of the final product. The full research article can be accessed for free through the provided link. [Extracted from the article] |
